Archives

  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-08
  • 2025-07
  • 2025-06
  • 2025-05
  • 2025-04

    • EZ Cap™ mCherry mRNA (5mCTP, ψUTP): Cap 1 Reporter mRNA f...

    2025-10-27

    EZ Cap™ mCherry mRNA (5mCTP, ψUTP): Cap 1 Reporter mRNA for Stable Red Fluorescent Protein Expression

    Executive Summary: EZ Cap™ mCherry mRNA (5mCTP, ψUTP) is a synthetic, Cap 1-structured messenger RNA encoding the red fluorescent protein mCherry, optimized for use as a reporter gene in molecular and cellular biology (ApexBio, 2024). The inclusion of 5-methylcytidine triphosphate (5mCTP) and pseudouridine triphosphate (ψUTP) suppresses RNA-mediated innate immune activation and improves mRNA stability both in vitro and in vivo. The mRNA is approximately 996 nucleotides in length, includes a poly(A) tail, and is supplied at 1 mg/mL in 1 mM sodium citrate buffer (pH 6.4). Cap 1 capping is enzymatically achieved using Vaccinia virus capping enzyme, GTP, SAM, and 2'-O-methyltransferase, closely mimicking mammalian mRNA and enhancing translation efficiency. The product is intended for advanced reporter workflows and should be stored at or below -40°C to maintain activity (ApexBio). Each of these claims is supported by vendor documentation and peer-reviewed molecular biology literature.

    Biological Rationale

    Reporter gene mRNAs are fundamental tools for monitoring gene expression, cell localization, and protein tracking in living systems (Roach 2024). Fluorescent proteins such as mCherry, a red fluorophore with excitation/emission maxima at 587/610 nm, enable non-destructive, real-time studies of cellular processes (FPbase, 2024). mCherry is derived from Discosoma sp. DsRed and is monomeric, reducing aggregation artifacts compared to tetrameric predecessors (FPbase). Incorporating synthetic mRNA encoding mCherry allows for transient, controlled expression, avoiding genomic integration and facilitating rapid experimental cycles. Cap 1 structures and modified nucleotides, such as 5mCTP and ψUTP, further optimize synthetic mRNAs by reducing immunogenicity and increasing stability, which is crucial for sensitive cell and tissue studies. The combination of these features in EZ Cap™ mCherry mRNA (5mCTP, ψUTP) addresses the primary limitations of unmodified synthetic mRNAs, such as rapid degradation and innate immune activation (ApexBio).

    Mechanism of Action of EZ Cap™ mCherry mRNA (5mCTP, ψUTP)

    • The mRNA sequence encodes the mCherry protein, enabling red fluorescence upon translation.
    • The Cap 1 structure is enzymatically added using Vaccinia virus capping enzyme (VCE), GTP, S-adenosylmethionine (SAM), and 2′-O-methyltransferase, closely matching mammalian mRNA caps (Shatkin 2011).
    • Cap 1 enhances translation efficiency and reduces recognition by innate immune sensors such as RIG-I (Shatkin 2011).
    • Modified nucleotides 5mCTP and ψUTP reduce double-stranded RNA formation and innate immune activation, prolonging mRNA half-life (Karikó 2014).
    • A poly(A) tail promotes ribosome recruitment and translation initiation, further stabilizing the mRNA (ApexBio).

    Evidence & Benchmarks

    • Cap 1-structured mRNAs exhibit higher translation efficiency and lower immunogenicity compared to Cap 0 or uncapped mRNA (Shatkin 2011, PMC3046393).
    • mRNAs incorporating 5mCTP and ψUTP modifications show significantly reduced activation of Toll-like receptors and cytosolic RNA sensors, resulting in diminished interferon responses (Karikó 2014, PubMed 24814492).
    • In vitro, mCherry mRNA with Cap 1 and nucleotide modifications yields robust, cytosol-localized red fluorescence in a variety of mammalian cell types, exceeding unmodified controls (Roach 2024, Pace University).
    • Reporter mRNAs with these modifications display enhanced stability and prolonged protein expression in vivo, supporting long-term tracking experiments (ApexBio, Product Page).
    • The mCherry open reading frame is 711 nucleotides, and the full-length mRNA (including UTRs, Cap, poly(A)) is approximately 996 nucleotides (ApexBio, Product Page).
    • mCherry's fluorescence emission maximum is 610 nm, with excitation at 587 nm (FPbase, FPbase).
    • Formulation with excipients such as trehalose or calcium acetate further improves mRNA stability during nanoparticle encapsulation and delivery (Roach 2024, Pace University).

    Applications, Limits & Misconceptions

    EZ Cap™ mCherry mRNA (5mCTP, ψUTP) is designed for use as a fluorescent reporter in molecular biology, cell imaging, and protein localization studies. It is suitable for direct transfection, encapsulation in lipid nanoparticles, and mesoscale nanoparticle platforms for both in vitro and in vivo applications (Roach 2024; ApexBio). The product is not intended for therapeutic use or for applications requiring long-term genomic integration. mRNA must be handled under RNase-free conditions, and storage at or below -40°C is critical for stability.

    Common Pitfalls or Misconceptions

    • The product is not suitable for permanent genetic modification; expression is transient and does not integrate into the genome.
    • Direct injection without a suitable delivery system (e.g., lipid nanoparticles) results in rapid mRNA degradation by nucleases.
    • The Cap 1 structure minimizes but does not completely abolish innate immune recognition in all cell types.
    • Not all transfection reagents are compatible; some may reduce mRNA integrity or translation efficiency.
    • Fluorescence intensity depends on both mRNA uptake and cellular translation machinery; low expression may reflect biological variability, not product failure.

    Workflow Integration & Parameters

    EZ Cap™ mCherry mRNA (5mCTP, ψUTP) is supplied at ~1 mg/mL in 1 mM sodium citrate, pH 6.4. For in vitro transfections, 100–500 ng per 105 cells is commonly used, adjusted per protocol. For nanoparticle-mediated delivery, the mRNA is compatible with standard lipid nanoparticle (LNP) and polymeric mesoscale nanoparticle (MNP) systems (Roach 2024). Quality assurance includes RNase-free handling, confirmation of mRNA size (~996 nt), and integrity checks by agarose gel or Bioanalyzer. Storage at or below -40°C is mandatory for long-term stability. For troubleshooting and optimization strategies, see Optimizing Reporter Studies with mCherry mRNA: Cap 1 Stru..., which discusses troubleshooting of transfection workflows and extends the technical details found here by focusing on protocol-level adjustments. For detailed guidance on maximizing translation efficiency, see Optimizing Fluorescent Protein Expression with mCherry mRNA; this article builds upon those recommendations by providing evidence-based benchmarks and limitations.

    Conclusion & Outlook

    EZ Cap™ mCherry mRNA (5mCTP, ψUTP) represents a robust, validated tool for high-fidelity reporter gene studies requiring red fluorescent protein expression. Its Cap 1 structure and modified nucleotides deliver superior stability, translation, and immune evasion compared to unmodified or Cap 0 mRNAs. Combined with modern delivery technologies, this product enables advanced molecular tracking and imaging in both basic and translational research. For expanded application notes and troubleshooting, the user is encouraged to consult EZ Cap™ mCherry mRNA (5mCTP, ψUTP): Structure, Function &..., which complements this article by detailing structural evidence and workflow integration steps.

    For full product specifications, protocols, and technical support, visit the EZ Cap™ mCherry mRNA (5mCTP, ψUTP) product page.